MiR-431 promotes cardiomyocyte proliferation by targeting FBXO32 expression

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Regenerative Medicine

Background:

• Cardiomyocyte (CM) proliferation is key for cardiac regeneration after injury.
• MicroRNAs (miRNAs) regulate CM proliferation, with miR-431 levels decreasing during cardiac development.
• The role of miR-431 in CM proliferation remains largely uninvestigated.

Purpose of the Study:

• To investigate the role of miR-431 in cardiomyocyte proliferation and cardiac repair.
• To identify the molecular mechanisms underlying miR-431's function in the heart.

Main Methods:

• Bioinformatic analysis of Gene Expression Omnibus (GEO) datasets to identify differentially expressed miRNAs.
• Quantitative PCR and in situ hybridization for miRNA expression profiling.
• In vitro and in vivo gain- and loss-of-function assays to assess miR-431's role in CM proliferation and cardiac function post-myocardial infarction.
• Bioinformatic prediction and luciferase reporter assays to identify and validate miR-431 target genes.

Main Results:

• miR-431 expression is significantly reduced during cardiac development.
• miR-431 overexpression promotes CM proliferation in vitro and in vivo, while inhibition suppresses it.
• miR-431 enhances cardiac function following myocardial infarction.
• FBXO32 was identified as a direct target of miR-431; FBXO32 inhibits CM proliferation, and its suppression by miR-431 mediates miR-431's pro-proliferative effect.

Conclusions:

• miR-431 promotes cardiomyocyte proliferation by targeting and suppressing FBXO32.
• miR-431 represents a promising molecular target for therapeutic intervention in myocardial injury and cardiac regeneration.